1. Home
  2. BDTX vs TGL Comparison

BDTX vs TGL Comparison

Compare BDTX & TGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • TGL
  • Stock Information
  • Founded
  • BDTX 2014
  • TGL 2020
  • Country
  • BDTX United States
  • TGL United States
  • Employees
  • BDTX N/A
  • TGL N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • TGL Retail: Computer Software & Peripheral Equipment
  • Sector
  • BDTX Health Care
  • TGL Technology
  • Exchange
  • BDTX Nasdaq
  • TGL Nasdaq
  • Market Cap
  • BDTX 181.4M
  • TGL 4.1M
  • IPO Year
  • BDTX 2020
  • TGL 2022
  • Fundamental
  • Price
  • BDTX $3.17
  • TGL $1.20
  • Analyst Decision
  • BDTX Strong Buy
  • TGL
  • Analyst Count
  • BDTX 6
  • TGL 0
  • Target Price
  • BDTX $12.50
  • TGL N/A
  • AVG Volume (30 Days)
  • BDTX 836.3K
  • TGL 6.2M
  • Earning Date
  • BDTX 11-04-2025
  • TGL 11-13-2025
  • Dividend Yield
  • BDTX N/A
  • TGL N/A
  • EPS Growth
  • BDTX N/A
  • TGL N/A
  • EPS
  • BDTX 0.25
  • TGL N/A
  • Revenue
  • BDTX $70,000,000.00
  • TGL $1,468,790.00
  • Revenue This Year
  • BDTX N/A
  • TGL N/A
  • Revenue Next Year
  • BDTX N/A
  • TGL N/A
  • P/E Ratio
  • BDTX $12.66
  • TGL N/A
  • Revenue Growth
  • BDTX N/A
  • TGL N/A
  • 52 Week Low
  • BDTX $1.20
  • TGL $0.70
  • 52 Week High
  • BDTX $6.23
  • TGL $76.50
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 59.42
  • TGL 54.36
  • Support Level
  • BDTX $3.13
  • TGL $0.70
  • Resistance Level
  • BDTX $3.43
  • TGL $1.78
  • Average True Range (ATR)
  • BDTX 0.17
  • TGL 0.16
  • MACD
  • BDTX 0.03
  • TGL 0.02
  • Stochastic Oscillator
  • BDTX 64.86
  • TGL 46.30

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. Its product is an internet application branded ZCITY app, that targets consumers by providing personalized deals based on consumers' purchase history, location and preferences.

Share on Social Networks: